Back to results
US 2019/0160060 A1Published application
Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
AssigneeGlobal Blood Therapeutics, Inc.
InventorBrian Metcalf
Life of this patent
Estimating the term…
Abstract
Provided are substituted benzaldehydes and derivatives thereof that act as allosteric modulators of hemoglobin, methods and intermediates for their preparation, pharmaceutical compositions comprising the modulators, and methods for their use in treating disorders mediate by hemoglobin and disorders that would benefit from increased tissue oxygenation.
Claims11
-17. (canceled)
A compound of Formula (I):
- or a pharmaceutically acceptable salt thereof,
- wherein:
- Q is monocyclic heteroaryl substituted with one to three Ra;
- R2, R3, and R4 are independently selected from hydrogen, halo, and ORd;
- Y is CH2;
- X is O or CH2;
- R5 is halo, OH, CHO, or OCH3;
- R6 and R7 together form oxo;
- each Ra is heteroaryl substituted one to three Rc;
- each Rc is independently selected from the group consisting C1-8alkyl and haloC1-8alkyl;
- Rd is hydrogen, C1-8 alkyl, haloC1-8 alkyl, C2-8 alkenyl, haloC2-8 alkenyl, C2-8 alkynyl, and haloC2-8 alkynyl.
8 more elements
Dependencies are inferred from the claim text.